695 results on '"Cho, Sang Nae"'
Search Results
2. 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
3. Evaluation of TBMDR® and XDRA® for the detection of multidrug resistant and pre-extensively drug resistant tuberculosis
4. Does the Effectiveness and Mechanical Strength of Kanamycin-Loaded Bone Cement in Musculoskeletal Tuberculosis Compare to Vancomycin-Loaded Bone Cement
5. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15
6. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study
7. Seroprevalence of tuberculosis in domesticated elk (Cervus canadensis) in Korea
8. Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis
9. Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K
10. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis
11. Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach
12. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
13. Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis
14. Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
15. Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses
16. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects
17. How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?
18. Diagnostic Performance of a Cytokine and IFN-γ–Induced Chemokine mRNA Assay after Mycobacterium tuberculosis–Specific Antigen Stimulation in Whole Blood from Infected Individuals
19. On the Origin of Leprosy
20. Centrifugal Lithography: Self‐Shaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops
21. Centrifugal Lithography: Centrifugal Lithography: Self‐Shaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops (Adv. Healthcare Mater. 19/2017)
22. Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
23. Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment
24. Detection of IFN-γ for latent tuberculosis diagnosis using an anodized aluminum oxide-based capacitive sensor
25. Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis
26. Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis
27. Association of lipoarabinomannan with high density lipoprotein in blood: Implications for diagnostics
28. Mycobacterial Genotypes Are Associated With Clinical Manifestation and Progression of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
29. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
30. The association between sterilizing activity and drug distribution into tuberculosis lesions
31. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis
32. Mycobacterium paratuberculosis CobT Activates Dendritic Cells via Engagement of Toll-like Receptor 4 Resulting in Th1 Cell Expansion
33. Performance of PCR-reverse blot hybridization assay for detection of rifampicin-resistant Mycobacterium leprae
34. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
35. Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor
36. Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients
37. Mutations in Extensively Drug-Resistant Mycobacterium tuberculosis That Do Not Code for Known Drug-Resistance Mechanisms
38. Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital
39. Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea
40. European 1: A globally important clonal complex of Mycobacterium bovis
41. Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients
42. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis
43. Performance of a real-time PCR assay for the rapid identification of Mycobacterium species
44. Characterization of a novel antigen of Mycobacterium tuberculosis K strain and its use in immunodiagnosis of tuberculosis
45. Identification of novel antitubercular compounds through hybrid virtual screening approach
46. Mycobacterium tuberculosis-Induced Expression of Leukotactin-1 Is Mediated by the PI3-K/PDK1/Akt Signaling Pathway
47. Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
48. A rapid assessing method of drug susceptibility using flow cytometry for Mycobacterium tuberculosis isolates resistant to INH, RIF and EMB
49. Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis
50. Linezolid for XDR-TB — Final Study Outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.